Gastroesophageal Reflux Disease (Gerd) Market 2024-2028

1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4.1 Global Gastroesophageal Reflux Disease (GERD) Market 2018 - 2022
Historic Market Size - Data Table on Global Gastroesophageal Reflux Disease (GERD) Market 2018 - 2022 ($ million)
4.2 Route of Administration segment analysis 2018 - 2022
Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6.1 Market segments
Chart on Route of Administration - Market share 2023-2028 (%)
Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ million)
Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.4 Parenteral - Market size and forecast 2023-2028
Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)

7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Antacid - Market size and forecast 2023-2028
Chart on Antacid - Market size and forecast 2023-2028 ($ million)
Data Table on Antacid - Market size and forecast 2023-2028 ($ million)
Chart on Antacid - Year-over-year growth 2023-2028 (%)
Data Table on Antacid - Year-over-year growth 2023-2028 (%)
7.4 PPI - Market size and forecast 2023-2028
Chart on PPI - Market size and forecast 2023-2028 ($ million)
Data Table on PPI - Market size and forecast 2023-2028 ($ million)
Chart on PPI - Year-over-year growth 2023-2028 (%)
Data Table on PPI - Year-over-year growth 2023-2028 (%)
7.5 H2 receptor antagonist drugs - Market size and forecast 2023-2028
Chart on H2 receptor antagonist drugs - Market size and forecast 2023-2028 ($ million)
Data Table on H2 receptor antagonist drugs - Market size and forecast 2023-2028 ($ million)
Chart on H2 receptor antagonist drugs - Year-over-year growth 2023-2028 (%)
Data Table on H2 receptor antagonist drugs - Year-over-year growth 2023-2028 (%)
7.6 Prokinetic drugs - Market size and forecast 2023-2028
Chart on Prokinetic drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Prokinetic drugs - Market size and forecast 2023-2028 ($ million)
Chart on Prokinetic drugs - Year-over-year growth 2023-2028 (%)
Data Table on Prokinetic drugs - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 Alkem Laboratories Ltd.
Alkem Laboratories Ltd. - Overview
Alkem Laboratories Ltd. - Business segments
Alkem Laboratories Ltd. - Key offerings
Alkem Laboratories Ltd. - Segment focus
12.5 Apotex Inc.
Apotex Inc. - Overview
Apotex Inc. - Product / Service
Apotex Inc. - Key news
Apotex Inc. - Key offerings
12.6 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.7 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
12.8 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.9 Cipla Inc.
Cipla Inc. - Overview
Cipla Inc. - Business segments
Cipla Inc. - Key news
Cipla Inc. - Key offerings
Cipla Inc. - Segment focus
12.10 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
12.11 Eisai Co. Ltd.
Eisai Co. Ltd. - Overview
Eisai Co. Ltd. - Business segments
Eisai Co. Ltd. - Key offerings
Eisai Co. Ltd. - Segment focus
12.12 Fresenius SE and Co. KGaA
Fresenius SE and Co. KGaA - Overview
Fresenius SE and Co. KGaA - Business segments
Fresenius SE and Co. KGaA - Key news
Fresenius SE and Co. KGaA - Key offerings
Fresenius SE and Co. KGaA - Segment focus
12.13 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.14 inovapharma.com
inovapharma.com - Overview
inovapharma.com - Product / Service
inovapharma.com - Key offerings
12.15 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.16 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
12.17 Perrigo Co. Plc
Perrigo Co. Plc - Overview
Perrigo Co. Plc - Business segments
Perrigo Co. Plc - Key offerings
Perrigo Co. Plc - Segment focus

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Gastroesophageal Reflux Disease (GERD) Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits 33: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Route of Administration
Exhibits 35: Data Table on Comparison by Route of Administration
Exhibits 36: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits 44: Market opportunity by Route of Administration ($ million)
Exhibits 45: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 46: Chart on Type - Market share 2023-2028 (%)
Exhibits 47: Data Table on Type - Market share 2023-2028 (%)
Exhibits 48: Chart on Comparison by Type
Exhibits 49: Data Table on Comparison by Type
Exhibits 50: Chart on Antacid - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Data Table on Antacid - Market size and forecast 2023-2028 ($ million)
Exhibits 52: Chart on Antacid - Year-over-year growth 2023-2028 (%)
Exhibits 53: Data Table on Antacid - Year-over-year growth 2023-2028 (%)
Exhibits 54: Chart on PPI - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on PPI - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on PPI - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on PPI - Year-over-year growth 2023-2028 (%)
Exhibits 58: Chart on H2 receptor antagonist drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on H2 receptor antagonist drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on H2 receptor antagonist drugs - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on H2 receptor antagonist drugs - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Prokinetic drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Prokinetic drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Prokinetic drugs - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Prokinetic drugs - Year-over-year growth 2023-2028 (%)
Exhibits 66: Market opportunity by Type ($ million)
Exhibits 67: Data Table on Market opportunity by Type ($ million)
Exhibits 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 69: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits 70: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits 71: Chart on Geographic comparison
Exhibits 72: Data Table on Geographic comparison
Exhibits 73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 109: Market opportunity By Geographical Landscape($ million)
Exhibits 110: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits 111: Impact of drivers and challenges in 2023 and 2028
Exhibits 112: Overview on criticality of inputs and factors of differentiation
Exhibits 113: Overview on factors of disruption
Exhibits 114: Impact of key risks on business
Exhibits 115: Companies covered
Exhibits 116: Matrix on companies position and classification
Exhibits 117: Abbott Laboratories - Overview
Exhibits 118: Abbott Laboratories - Business segments
Exhibits 119: Abbott Laboratories - Key news
Exhibits 120: Abbott Laboratories - Key offerings
Exhibits 121: Abbott Laboratories - Segment focus
Exhibits 122: Alkem Laboratories Ltd. - Overview
Exhibits 123: Alkem Laboratories Ltd. - Business segments
Exhibits 124: Alkem Laboratories Ltd. - Key offerings
Exhibits 125: Alkem Laboratories Ltd. - Segment focus
Exhibits 126: Apotex Inc. - Overview
Exhibits 127: Apotex Inc. - Product / Service
Exhibits 128: Apotex Inc. - Key news
Exhibits 129: Apotex Inc. - Key offerings
Exhibits 130: AstraZeneca Plc - Overview
Exhibits 131: AstraZeneca Plc - Product / Service
Exhibits 132: AstraZeneca Plc - Key news
Exhibits 133: AstraZeneca Plc - Key offerings
Exhibits 134: Aurobindo Pharma Ltd. - Overview
Exhibits 135: Aurobindo Pharma Ltd. - Product / Service
Exhibits 136: Aurobindo Pharma Ltd. - Key offerings
Exhibits 137: Bayer AG - Overview
Exhibits 138: Bayer AG - Business segments
Exhibits 139: Bayer AG - Key news
Exhibits 140: Bayer AG - Key offerings
Exhibits 141: Bayer AG - Segment focus
Exhibits 142: Cipla Inc. - Overview
Exhibits 143: Cipla Inc. - Business segments
Exhibits 144: Cipla Inc. - Key news
Exhibits 145: Cipla Inc. - Key offerings
Exhibits 146: Cipla Inc. - Segment focus
Exhibits 147: Dr Reddys Laboratories Ltd. - Overview
Exhibits 148: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 149: Dr Reddys Laboratories Ltd. - Key news
Exhibits 150: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 151: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 152: Eisai Co. Ltd. - Overview
Exhibits 153: Eisai Co. Ltd. - Business segments
Exhibits 154: Eisai Co. Ltd. - Key offerings
Exhibits 155: Eisai Co. Ltd. - Segment focus
Exhibits 156: Fresenius SE and Co. KGaA - Overview
Exhibits 157: Fresenius SE and Co. KGaA - Business segments
Exhibits 158: Fresenius SE and Co. KGaA - Key news
Exhibits 159: Fresenius SE and Co. KGaA - Key offerings
Exhibits 160: Fresenius SE and Co. KGaA - Segment focus
Exhibits 161: GlaxoSmithKline Plc - Overview
Exhibits 162: GlaxoSmithKline Plc - Business segments
Exhibits 163: GlaxoSmithKline Plc - Key news
Exhibits 164: GlaxoSmithKline Plc - Key offerings
Exhibits 165: GlaxoSmithKline Plc - Segment focus
Exhibits 166: inovapharma.com - Overview
Exhibits 167: inovapharma.com - Product / Service
Exhibits 168: inovapharma.com - Key offerings
Exhibits 169: Johnson and Johnson Services Inc. - Overview
Exhibits 170: Johnson and Johnson Services Inc. - Business segments
Exhibits 171: Johnson and Johnson Services Inc. - Key news
Exhibits 172: Johnson and Johnson Services Inc. - Key offerings
Exhibits 173: Johnson and Johnson Services Inc. - Segment focus
Exhibits 174: Lupin Ltd. - Overview
Exhibits 175: Lupin Ltd. - Product / Service
Exhibits 176: Lupin Ltd. - Key news
Exhibits 177: Lupin Ltd. - Key offerings
Exhibits 178: Perrigo Co. Plc - Overview
Exhibits 179: Perrigo Co. Plc - Business segments
Exhibits 180: Perrigo Co. Plc - Key offerings
Exhibits 181: Perrigo Co. Plc - Segment focus
Exhibits 182: Inclusions checklist
Exhibits 183: Exclusions checklist
Exhibits 184: Currency conversion rates for US$
Exhibits 185: Research methodology
Exhibits 186: Information sources
Exhibits 187: Data validation
Exhibits 188: Validation techniques employed for market sizing
Exhibits 189: Data synthesis
Exhibits 190: 360 degree market analysis
Exhibits 191: List of abbreviations